Evidence map›Paper›PMID 42794877›Full record

ArticleCancers2026

Treatment Outcomes and Toxicity of Cisplatin-Etoposide-Based Regimens and Carboplatin-Paclitaxel as Adjuvant Chemotherapy for Ovarian Adult Granulosa Cell Tumors: A Multicenter Retrospective Cohort Study.

Aslı Geçgel, Mehmet Uzun, Mehmet Burak Kaya, Seval Ay Ersoy, Tuba Uğur Tuzcu, Tuğba Kaya, Yiğit Efe Sürgen, Ekin Kavvasoğlu Durmuş, Canan Kelten Talu, Zafer Arık and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Aslı GeçgelDepartment of Medical Oncology, Ege University Faculty of Medicine, 35100 Izmir, Türkiye.
Mehmet UzunDepartment of Medical Oncology, Izmir Tepecik Training and Research Hospital, 35020 Izmir, Türkiye.
Mehmet Burak KayaDepartment of Medical Oncology, Hacettepe University Faculty of Medicine, 06230 Ankara, Türkiye.
Seval Ay ErsoyDepartment of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, 34865 Istanbul, Türkiye.
Tuba Uğur TuzcuDepartment of Medical Oncology, Gazi University Faculty of Medicine, 06560 Ankara, Türkiye.
Tuğba KayaDepartment of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, 34865 Istanbul, Türkiye.
Yiğit Efe SürgenDepartment of Internal Medicine, Ege University Faculty of Medicine, 35100 Izmir, Türkiye.
Ekin Kavvasoğlu DurmuşDepartment of Internal Medicine, Tepecik Training and Research Hospital, 35020 Izmir, Türkiye.
Canan Kelten TaluDepartment of Medical Pathology, Tepecik Training and Research Hospital, 35020 Izmir, Türkiye.
Zafer ArıkDepartment of Medical Oncology, Hacettepe University Faculty of Medicine, 06230 Ankara, Türkiye.
Osman SütçüoğluDepartment of Medical Oncology, Gazi University Faculty of Medicine, 06560 Ankara, Türkiye.
Nuri YıldırımDepartment of Obstetrics and Gynecology, Ege University Faculty of Medicine, 35100 Izmir, Türkiye.ORCID 0000-0002-0605-4750
Erdem GökerDepartment of Medical Oncology, Ege University Faculty of Medicine, 35100 Izmir, Türkiye.ORCID 0000-0001-6180-713X
Sercan ÖnDepartment of Medical Oncology, Ege University Faculty of Medicine, 35100 Izmir, Türkiye.ORCID 0000-0003-1461-7485

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant chemotherapyadult granulosa cell tumorbleomycin–etoposide–cisplatincarboplatin–paclitaxeldisease-free survivalmulticenter studyplatinum-based chemotherapytoxicity

Identifiers

PMID42794877
PMCPMC13604064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.